Women’s Health

Mother-baby drug to be phased out as single therapy

The Medicines Control Council, has recommended to the Health Ministry that it stop using nevirapine as a single agent in the prevention of mother-to-child-HIV-transmission. Health-e caught up with the Registrar of medicines Precious Matsoso, at the XV International AIDS
Conference in Bangkok, Thailand, and asked her why the MCC made the decision.

Read More » Mother-baby drug to be phased out as single therapy

Newsletter Subscription

Be in the know with our free weekly newsletter. We deliver a round-up of our top stories and insightful reads from across the web.

  • This field is for validation purposes and should be left unchanged.

Enable Notifications OK No thanks